5 November, 2018

Enhance R & D and protect intellectual property, petitions from the pharmaceutical industry to Europe

Source: actasanitaria.com In order to highlight the priorities of the sector when there are just over seven months left for the next European elections, a manifesto, […]
30 October, 2018

The AEMPS publishes new features in the treatment of drug registration dossiers

Source: actasanitaria.com The Spanish Agency for Medicines and Health Products (AEMPS) has published the news regarding the submission of requests for regulatory activities of medicines for […]
25 October, 2018

Cataluña allocates 9.5 million to Peris, its health innovation plan

Source: redaccionmedica.com The government has approved this Tuesday for 9.550.000 euros to attend the 2019 call for grants of the Strategic Plan for Research and Innovation […]
23 October, 2018

New advances in the treatment of head and neck tumors

Source: immedicohospitalario.es Immunotherapy with pembrolizumab improves survival in patients with head and neck cancer that has recurred or metastasized according to the most recent results of […]
19 October, 2018

Gilead increases its commitment to research in Spain targeting HIV

Source: redaccionmedica.com The biopharmaceutical company Gilead Sciences continues its commitment to research in our country, this time, developing a project to achieve the cure of HIV. […]
18 October, 2018

Breast cancer: the industry leads the research of 169 new drugs

Source: redaccionmedica.com Currently, the pharmaceutical industry has a total of 169 new drugs against breast cancer in the clinical research phase, a disease that encompasses the […]
16 October, 2018

Success of the first trial of Opsumit (Actelion) in portopulmonary hypertension

Source: redaccionmedica.com Actelion Pharmaceuticals has announced the results of the first randomized controlled trial in portopulmonary hypertension (HTPP). This study has shown that Opsumit (macitentan) significantly […]
10 October, 2018

Europe approves Verzenios, from Lilly, for the treatment of advanced breast cancer

Source: actasanitaria.com The European Commission has authorized the commercialization of Verzenios (abemaciclib), from the pharmaceutical company Lilly, as a treatment of locally advanced or metastatic breast […]
8 October, 2018

Genetic mutations also alter the nature of clinical trials

Source: immedicohospitalario.es New ways of researching and developing drugs, in their most advanced oncological aspects, urge health administrations, hospitals, patients and their organizations, Research Ethics Committees […]
5 October, 2018

VHIO develops a precision immunotherapy for breast cancer

Source: redaccionmedica.com Researchers at the Vall d’Hebron Institute of Oncology (VHIO) in Barcelona have achieved that immunotherapy attacks only the tumor cells of a type of […]
3 October, 2018

Nobel Prize for Medicine 2018 for cancer immunotherapy

Source: IntraMed The American James Allison and the Japanese Tasuku Honjo have won the Nobel Prize for Medicine 2018. The jury of the Karolinska Institute in […]
26 September, 2018

EMA gives a positive opinion to Gilenya, from Novartis, for minors with multiple sclerosis

Source: actasanitaria.com The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended the approval of the drug Gilenya (fingolimod), […]
Private zoneHoja de Validación
Reembolso de Gastos